SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 83 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2014. The put-call ratio across all filers is 2.83 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $166,000 | -3.5% | 640,792 | -10.8% | 0.00% | – |
| Q1 2016 | $172,000 | -31.7% | 718,211 | -0.1% | 0.00% | – |
| Q4 2015 | $252,000 | -79.8% | 718,596 | +0.1% | 0.00% | -100.0% |
| Q3 2015 | $1,249,000 | -16.1% | 717,826 | +7.6% | 0.00% | 0.0% |
| Q2 2015 | $1,488,000 | +50.8% | 667,426 | +31.1% | 0.00% | 0.0% |
| Q1 2015 | $987,000 | -14.8% | 509,162 | +16.5% | 0.00% | 0.0% |
| Q4 2014 | $1,158,000 | -11.7% | 436,982 | +0.3% | 0.00% | 0.0% |
| Q3 2014 | $1,311,000 | -17.7% | 435,827 | +11.9% | 0.00% | 0.0% |
| Q2 2014 | $1,593,000 | +1.9% | 389,640 | +7.4% | 0.00% | 0.0% |
| Q1 2014 | $1,563,000 | +11.8% | 362,723 | +36.0% | 0.00% | 0.0% |
| Q4 2013 | $1,398,000 | +8.0% | 266,794 | +30.1% | 0.00% | 0.0% |
| Q3 2013 | $1,294,000 | +41.4% | 205,120 | +11.8% | 0.00% | 0.0% |
| Q2 2013 | $915,000 | – | 183,397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 30,197,945 | $80,025,000 | 92.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 457,458 | $1,212,000 | 0.22% |
| Verity Asset Management, Inc. | 82,383 | $218,000 | 0.21% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,238 | $880,000 | 0.12% |
| Cutler Capital Management, LLC | 62,500 | $165,000 | 0.07% |
| Capital Impact Advisors, LLC | 37,788 | $100,000 | 0.05% |
| SECOR Capital Advisors, LP | 35,087 | $93,000 | 0.04% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 50,814 | $134,000 | 0.04% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |